ClinicalTrials.gg
Sign In

Lipodystrophy clinical trials

The registry lists 139 studies for Lipodystrophy across more than 10 countries. 10 are recruiting or about to start. 55 of them are mainly about Lipodystrophy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as HIV-Associated Lipodystrophy Syndrome: 167 studies, 12 open.

Get an email when these change. Save the Lipodystrophy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
105
Status unknown
14
Recruiting
7
Terminated
4
Active, not recruiting
3
Not yet recruiting
2

Phase

Phase 4
24
Phase 2
20
Phase 1
9
Phase 3
9
Early Phase 1
1

Where

United States
77
France
11
Spain
7
Canada
6
Puerto Rico
5
Romania
5

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (15) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (13) · University of Texas Southwestern Medical Center (7) · Massachusetts General Hospital (5) · Centre Hospitalier Universitaire de la Réunion (5) · I.R.A. Istituto Ricerche Applicate S.p.A. (4) · Kirby Institute (4) · Glaxo Wellcome (3)

What is being tested here

Drugs under test in Lipodystrophy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Metreleptin017
Human Growth Hormone014
Tesamorelin023
Pioglitazone003
Nelfinavir003
Rosiglitazone003
Ritonavir003
Leptin012
Pravastatin012
Efavirenz002

Drug classes tested here Reverse transcriptase inhibitors 5

Coming up

1phase 3 study under way
4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Who these studies take

Of the 7 Lipodystrophy studies recruiting now, 3 (43%) set no upper age limit and 3 (43%) stop at 75 or younger. 5 (71%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 7
AgeWomenMen
105 (71%)5 (71%)
186 (86%)6 (86%)
306 (86%)6 (86%)
406 (86%)6 (86%)
506 (86%)6 (86%)
656 (86%)6 (86%)
754 (57%)4 (57%)
854 (57%)4 (57%)

Across all 139 studies, recruiting or not: 42% stop at 75 or younger and 32% at 65; 25% take children; 6% are for women only and 2% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lipodystrophy studies take

Of 23 interventional studies with no phase under Lipodystrophy, half reached primary completion within 11 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase11 mo7–23 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 139. Browse all 139 → or search them.